212 is the total number of securities Healthcare Value Capital, LLC has owned. The longest Healthcare Value Capital, LLC has owned a single stock is 20 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| GILD | GILEAD SCIENCES INC | 11 | 9 | 3.13% | 11.71% | 31.33% | Q3 2016 | Q3 2021 | 20 |
| GSK | GLAXOSMITHKLINE PLC | 17 | 3 | 1.66% | 8.54% | 16.10% | Q2 2013 | Q3 2021 | 20 |
| PFE | PFIZER INC | 15 | 1 | 2.10% | 7.89% | 17.86% | Q1 2014 | Q3 2021 | 19 |
| TYME | TYME TECHNOLOGIES INC | 17 | 17 | 3.77% | 12.96% | 40.26% | Q3 2017 | Q3 2021 | 17 |
| AZN | ASTRAZENECA PLC | 10 | 1 | 2.43% | 5.74% | 12.86% | Q2 2013 | Q3 2021 | 14 |
| DGX | QUEST DIAGNOSTICS INC | 14 | 14 | 2.93% | 5.56% | 9.46% | Q2 2013 | Q3 2016 | 14 |
| CRY | CRYOLIFE INC | 11 | 2 | 0.54% | 3.72% | 6.60% | Q2 2013 | Q1 2017 | 13 |
| ATRS | ANTARES PHARMA INC | 9 | 4 | 0.73% | 3.30% | 6.72% | Q2 2018 | Q3 2021 | 13 |
| AMRN | AMARIN CORP PLC | 7 | 1 | 0.51% | 1.77% | 4.94% | Q4 2014 | Q3 2021 | 13 |
| CYTK | CYTOKINETICS INC | 8 | 5 | 0.17% | 0.84% | 1.73% | Q2 2013 | Q3 2016 | 13 |
| ANIP | ANI PHARMACEUTICALS INC | 7 | 5 | 2.74% | 12.78% | 23.89% | Q3 2013 | Q4 2016 | 12 |
| AMRI | ALBANY MOLECULAR RESH INC | 10 | 2 | 4.93% | 9.60% | 17.80% | Q1 2014 | Q1 2017 | 12 |
| NVLNF | NOVELION THERAPEUTICS INC | 12 | 12 | 1.83% | 9.41% | 15.27% | Q4 2016 | Q3 2019 | 12 |
| QLTI | QLT INC | 8 | 4 | 1.16% | 4.80% | 9.49% | Q2 2013 | Q3 2016 | 12 |
| FCSC | FIBROCELL SCIENCE INC | 12 | 12 | 0.03% | 0.55% | 1.11% | Q1 2014 | Q4 2016 | 12 |
| SPY | SPDR S&P 500 ETF TR | 5 | 2 | 2.91% | 12.77% | 26.80% | Q2 2013 | Q3 2019 | 11 |
| AGN | ALLERGAN PLC | 4 | 3 | 3.19% | 7.11% | 16.92% | Q2 2015 | Q1 2019 | 11 |
| TWM | PROSHARES TR | 11 | 11 | 0.75% | 3.72% | 10.69% | Q1 2014 | Q3 2016 | 11 |
| TEVA | TEVA PHARMACEUTICAL IN... | 7 | 3 | 1.62% | 4.75% | 10.51% | Q3 2013 | Q2 2017 | 10 |
| AMRN | AMARIN CORP PLC | 9 | 1 | 0.51% | 4.64% | 17.71% | Q1 2015 | Q3 2018 | 10 |
| CLVS | CLOVIS ONCOLOGY INC | 9 | 1 | 1.09% | 4.05% | 7.04% | Q3 2014 | Q3 2021 | 10 |
| GNLN | GREENLANE HLDGS INC | 10 | 10 | 0.65% | 2.35% | 4.50% | Q2 2019 | Q3 2021 | 10 |
| GILD | GILEAD SCIENCES INC | 6 | 1 | 4.39% | 8.60% | 19.01% | Q3 2016 | Q1 2020 | 9 |
| BIS | PROSHARES TR | 7 | 2 | 1.03% | 4.95% | 13.41% | Q1 2015 | Q4 2018 | 9 |
| SRNE | SORRENTO THERAPEUTICS INC | 9 | 9 | 0.40% | 1.18% | 3.32% | Q1 2014 | Q1 2016 | 9 |
| SNSS | SUNESIS PHARMACEUTICAL... | 6 | 3 | 0.10% | 0.60% | 2.21% | Q1 2014 | Q2 2016 | 9 |
| STML | STEMLINE THERAPEUTICS INC | 9 | 9 | 0.20% | 0.34% | 0.65% | Q3 2013 | Q3 2015 | 9 |
| DEPO | DEPOMED INC | 8 | 8 | 6.00% | 8.54% | 13.84% | Q4 2015 | Q3 2017 | 8 |
| ABBV | ABBVIE INC | 6 | 2 | 1.76% | 7.37% | 13.03% | Q2 2015 | Q4 2020 | 8 |
| FLDM | FLUIDIGM CORP DEL | 8 | 8 | 2.62% | 7.13% | 15.08% | Q1 2017 | Q4 2018 | 8 |
| BIS | PROSHARES TR | 3 | 1 | 0.94% | 3.89% | 9.05% | Q1 2015 | Q1 2020 | 8 |
| MRK | MERCK & CO INC NEW | 5 | 3 | 0.57% | 3.54% | 6.20% | Q2 2013 | Q3 2021 | 8 |
| ADMS | ADAMAS PHARMACEUTICALS... | 5 | 3 | 0.97% | 1.60% | 2.74% | Q1 2019 | Q3 2021 | 8 |
| SNSS | SUNESIS PHARMACEUTICAL... | 4 | 4 | 0.17% | 0.46% | 0.93% | Q2 2013 | Q2 2015 | 8 |
| ZGNX | ZOGENIX INC | 6 | 2 | 0.17% | 0.40% | 0.75% | Q2 2013 | Q2 2015 | 8 |
| VKTX | VIKING THERAPEUTICS INC | 7 | 7 | 2.97% | 5.12% | 9.57% | Q2 2018 | Q4 2019 | 7 |
| TWM | PROSHARES TR | 5 | 2 | 2.11% | 4.75% | 10.82% | Q1 2014 | Q2 2016 | 7 |
| CAH | CARDINAL HEALTH INC | 6 | 1 | 2.39% | 4.53% | 6.66% | Q2 2013 | Q4 2020 | 7 |
| APRI | APRICUS BIOSCIENCES INC | 7 | 7 | 0.21% | 0.66% | 1.35% | Q1 2015 | Q3 2016 | 7 |
| ZGNX | ZOGENIX INC | 7 | 7 | 0.31% | 0.53% | 0.78% | Q3 2015 | Q1 2017 | 7 |
| MCK | MCKESSON CORP | 6 | 6 | 2.47% | 4.49% | 5.86% | Q3 2019 | Q4 2020 | 6 |
| AMRI | ALBANY MOLECULAR RESH INC | 2 | 2 | 0.82% | 1.79% | 3.57% | Q1 2014 | Q2 2016 | 6 |
| SUPN | SUPERNUS PHARMACEUTICA... | 5 | 1 | 0.55% | 1.41% | 2.10% | Q2 2013 | Q2 2015 | 6 |
| ARIA | ARIAD PHARMACEUTICALS INC | 6 | 6 | 0.40% | 0.91% | 1.88% | Q2 2014 | Q3 2015 | 6 |
| RIGL | RIGEL PHARMACEUTICALS INC | 6 | 6 | 0.30% | 0.68% | 1.66% | Q4 2013 | Q1 2015 | 6 |
| QLTI | QLT INC | 2 | 1 | 0.07% | 0.49% | 1.10% | Q3 2013 | Q2 2016 | 6 |
| IWM | ISHARES TR | 5 | 5 | 3.80% | 7.81% | 14.07% | Q2 2013 | Q2 2014 | 5 |
| TEVA | TEVA PHARMACEUTICAL IN... | 4 | 1 | 2.59% | 4.00% | 5.88% | Q2 2013 | Q1 2015 | 5 |
| AUXL | AUXILIUM PHARMACEUTICA... | 5 | 5 | 3.19% | 4.00% | 5.09% | Q2 2013 | Q2 2014 | 5 |
| VIXY | PROSHARES TR II | 3 | 2 | 1.00% | 2.83% | 7.05% | Q2 2019 | Q1 2021 | 5 |
| DEPO | DEPOMED INC | 3 | 2 | 1.93% | 2.67% | 4.83% | Q1 2016 | Q2 2017 | 5 |
| SNY | SANOFI | 5 | 5 | 1.22% | 1.70% | 2.58% | Q2 2013 | Q2 2014 | 5 |
| SGNT | SAGENT PHARMACEUTICALS... | 3 | 2 | 0.90% | 1.16% | 1.56% | Q2 2013 | Q2 2016 | 5 |
| CRY | CRYOLIFE INC | 3 | 2 | 0.18% | 0.55% | 0.81% | Q2 2013 | Q2 2016 | 5 |
| CLSN | CELSION CORPORATION | 5 | 5 | 0.23% | 0.31% | 0.43% | Q1 2014 | Q1 2015 | 5 |
| MDY | SPDR S&P MIDCAP 400 ET... | 4 | 4 | 3.81% | 7.37% | 12.54% | Q2 2013 | Q1 2014 | 4 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 4 | 4 | 5.03% | 6.92% | 11.75% | Q1 2020 | Q4 2020 | 4 |
| CVS | CVS HEALTH CORP | 4 | 4 | 2.49% | 5.82% | 10.94% | Q3 2019 | Q2 2020 | 4 |
| MNKD | MANNKIND CORP | 4 | 4 | 1.20% | 4.58% | 8.78% | Q1 2015 | Q4 2015 | 4 |
| ABC | AMERISOURCEBERGEN CORP | 4 | 4 | 2.98% | 4.08% | 5.00% | Q3 2019 | Q2 2020 | 4 |
| SUPN | SUPERNUS PHARMACEUTICA... | 4 | 4 | 0.62% | 3.84% | 5.81% | Q2 2013 | Q1 2014 | 4 |
| AUXL | AUXILIUM PHARMACEUTICA... | 3 | 1 | 1.68% | 3.65% | 5.76% | Q2 2013 | Q3 2014 | 4 |
| GSK | GLAXOSMITHKLINE PLC | 3 | 1 | 0.91% | 3.18% | 5.48% | Q2 2013 | Q1 2016 | 4 |
| ARLZ | ARALEZ PHARMACEUTICALS... | 4 | 4 | 0.52% | 2.49% | 4.42% | Q1 2016 | Q4 2016 | 4 |
| VKTX | VIKING THERAPEUTICS INC | 2 | 2 | 0.79% | 2.36% | 3.83% | Q4 2018 | Q2 2020 | 4 |
| GMDA | GAMIDA CELL LTD | 4 | 4 | 0.77% | 1.01% | 1.42% | Q4 2020 | Q3 2021 | 4 |
| BOTA | BIOTA PHARMACEUTIALS INC | 4 | 4 | 0.35% | 0.66% | 0.98% | Q3 2013 | Q2 2014 | 4 |
| ALIM | ALIMERA SCIENCES INC | 4 | 4 | 0.32% | 0.59% | 1.01% | Q4 2014 | Q3 2015 | 4 |
| APRI | APRICUS BIOSCIENCES INC | 4 | 4 | 0.08% | 0.23% | 0.56% | Q4 2017 | Q3 2018 | 4 |
| SPXU | PROSHARES TR | 3 | 3 | 6.08% | 6.93% | 7.53% | Q1 2020 | Q3 2020 | 3 |
| MRK | MERCK & CO INC NEW | 2 | 1 | 5.20% | 5.89% | 6.74% | Q2 2013 | Q3 2014 | 3 |
| ALKS | ALKERMES PLC | 3 | 3 | 4.16% | 5.86% | 7.33% | Q1 2021 | Q3 2021 | 3 |
| BMY | BRISTOL-MYERS SQUIBB CO | 3 | 3 | 3.51% | 5.34% | 6.66% | Q1 2021 | Q3 2021 | 3 |
| AMYT | AMRYT PHARMA PLC | 3 | 3 | 4.83% | 5.21% | 5.97% | Q1 2021 | Q3 2021 | 3 |
| AZN | ASTRAZENECA PLC | 1 | 1 | 0.86% | 5.16% | 11.19% | Q2 2013 | Q1 2015 | 3 |
| IRWD | IRONWOOD PHARMACEUTICA... | 3 | 3 | 4.98% | 5.09% | 5.16% | Q1 2021 | Q3 2021 | 3 |
| WBA | WALGREENS BOOTS ALLIAN... | 2 | 1 | 1.92% | 4.11% | 5.41% | Q3 2019 | Q2 2020 | 3 |
| SPXU | PROSHARES TR | 3 | 3 | 1.82% | 4.09% | 5.27% | Q1 2021 | Q3 2021 | 3 |
| SPXU | PROSHARES TR | 3 | 3 | 2.87% | 3.98% | 6.02% | Q1 2020 | Q3 2020 | 3 |
| LGND | LIGAND PHARMACEUTICALS... | 3 | 3 | 2.27% | 3.78% | 4.86% | Q3 2014 | Q1 2015 | 3 |
| ENDP | ENDO HEALTH SOLUTIONS INC | 3 | 3 | 2.48% | 3.70% | 5.96% | Q2 2013 | Q4 2013 | 3 |
| VYNE | VYNE THERAPEUTICS INC | 3 | 3 | 1.10% | 3.45% | 6.10% | Q1 2021 | Q3 2021 | 3 |
| FRX | FOREST LABS INC | 3 | 3 | 2.54% | 2.76% | 3.10% | Q2 2013 | Q4 2013 | 3 |
| HNT | HEALTH NET INC | 3 | 3 | 2.18% | 2.39% | 2.77% | Q3 2013 | Q1 2014 | 3 |
| BIS | PROSHARES TR | 3 | 3 | 1.46% | 2.06% | 2.39% | Q1 2014 | Q3 2014 | 3 |
| CLVS | CLOVIS ONCOLOGY INC | 3 | 3 | 1.07% | 1.95% | 3.07% | Q4 2019 | Q2 2020 | 3 |
| ALQA | ALLIQUA BIOMEDICAL INC | 3 | 3 | 1.11% | 1.78% | 2.33% | Q1 2015 | Q3 2015 | 3 |
| HNT | HEALTH NET INC | 3 | 3 | 1.09% | 1.57% | 2.22% | Q3 2013 | Q1 2014 | 3 |
| AEGR | AEGERION PHARMACEUTICA... | 3 | 3 | 0.71% | 1.09% | 1.59% | Q1 2015 | Q3 2015 | 3 |
| CRTX | CORNERSTONE THERAPEUTI... | 3 | 3 | 0.35% | 1.08% | 1.65% | Q2 2013 | Q4 2013 | 3 |
| ATRS | ANTARES PHARMA INC | 2 | 1 | 0.73% | 1.06% | 1.23% | Q2 2018 | Q3 2019 | 3 |
| ARIA | ARIAD PHARMACEUTICALS INC | 3 | 3 | 0.52% | 0.89% | 1.26% | Q3 2014 | Q1 2015 | 3 |
| FLDM | FLUIDIGM CORP DEL | 3 | 3 | 0.49% | 0.86% | 1.09% | Q1 2017 | Q3 2017 | 3 |
| LCI | LANNET INC | 2 | 1 | 0.48% | 0.79% | 1.32% | Q1 2016 | Q4 2018 | 3 |
| KIN | KINDRED BIOSCIENCES INC | 2 | 1 | 0.41% | 0.55% | 0.78% | Q4 2013 | Q3 2014 | 3 |
| FOLD | AMICUS THERAPEUTICS INC | 3 | 3 | 0.27% | 0.33% | 0.43% | Q3 2013 | Q1 2014 | 3 |
| FCSC | FIBROCELL SCIENCE INC | 3 | 3 | 0.02% | 0.05% | 0.07% | Q2 2017 | Q4 2017 | 3 |
| VYNE | VYNE THERAPEUTICS INC | 2 | 2 | 9.85% | 10.25% | 10.65% | Q3 2020 | Q4 2020 | 2 |
| LGND | LIGAND PHARMACEUTICALS... | 2 | 2 | 5.35% | 8.73% | 12.11% | Q1 2019 | Q2 2019 | 2 |
| IBB | ISHARES TR | 1 | 1 | 3.15% | 7.82% | 12.50% | Q2 2013 | Q4 2013 | 2 |
| MNLO | MENLO THERAPEUTICS INC | 2 | 2 | 3.83% | 5.67% | 7.51% | Q1 2020 | Q2 2020 | 2 |
| B108PS | ACTAVIS PLC | 1 | 1 | 3.24% | 5.11% | 6.98% | Q3 2014 | Q1 2015 | 2 |
| PFE | PFIZER INC | 1 | 1 | 4.50% | 5.10% | 5.71% | Q4 2013 | Q3 2014 | 2 |
| COLL | COLLEGIUM PHARMACEUTIC... | 2 | 2 | 4.71% | 4.99% | 5.28% | Q1 2021 | Q2 2021 | 2 |
| ANIP | ANI PHARMACEUTICALS INC | 2 | 2 | 3.38% | 4.32% | 5.26% | Q2 2016 | Q3 2016 | 2 |
| VIXY | PROSHARES TR II | 1 | 1 | 1.71% | 3.24% | 4.78% | Q4 2016 | Q2 2017 | 2 |
| IPXL | IMPAX LABORATORIES INC | 1 | 1 | 1.74% | 3.03% | 4.33% | Q3 2013 | Q1 2017 | 2 |
| AMAG | AMAG PHARMACEUTICALS INC | 2 | 2 | 2.91% | 2.98% | 3.04% | Q2 2016 | Q3 2016 | 2 |
| MRNA | MODERNA INC | 2 | 2 | 2.33% | 2.93% | 3.52% | Q3 2020 | Q4 2020 | 2 |
| SQQQ | PROSHARES TR | 2 | 2 | 1.82% | 2.61% | 3.41% | Q2 2021 | Q3 2021 | 2 |
| FOMX | FOAMIX PHARMACEUTICALS... | 2 | 2 | 1.37% | 2.40% | 3.43% | Q3 2019 | Q4 2019 | 2 |
| SNY | SANOFI | 1 | 1 | 0.93% | 2.22% | 3.50% | Q2 2013 | Q1 2015 | 2 |
| VXX | BARCLAYS BK PLC | 1 | 1 | 1.38% | 2.19% | 3.01% | Q1 2014 | Q3 2014 | 2 |
| HUM | HUMANA INC | 2 | 2 | 1.63% | 2.04% | 2.45% | Q2 2013 | Q3 2013 | 2 |
| NVAX | NOVAVAX INC | 2 | 2 | 1.79% | 1.83% | 1.88% | Q3 2020 | Q4 2020 | 2 |
| ANIP | ANI PHARMACEUTICALS INC | 2 | 2 | 1.41% | 1.64% | 1.87% | Q3 2015 | Q4 2015 | 2 |
| ADMS | ADAMAS PHARMACEUTICALS... | 2 | 2 | 0.97% | 1.60% | 2.23% | Q4 2019 | Q1 2020 | 2 |
| GIVN | GIVEN IMAGING | 2 | 2 | 1.12% | 1.48% | 1.85% | Q2 2013 | Q3 2013 | 2 |
| ACT | ACTAVIS INC | 2 | 2 | 1.15% | 1.36% | 1.58% | Q2 2013 | Q3 2013 | 2 |
| IMMU | IMMUNOMEDICS INC | 2 | 2 | 1.11% | 1.35% | 1.59% | Q1 2017 | Q2 2017 | 2 |
| IRWD | IRONWOOD PHARMACEUTICA... | 2 | 2 | 1.24% | 1.26% | 1.28% | Q1 2021 | Q2 2021 | 2 |
| VIXY | PROSHARES TR II | 1 | 1 | 1.11% | 1.26% | 1.41% | Q2 2015 | Q2 2016 | 2 |
| V107SC | WELLPOINT INC | 2 | 2 | 1.10% | 1.22% | 1.34% | Q2 2013 | Q3 2013 | 2 |
| PCRX | PACIRA PHARMACEUTICALS... | 2 | 2 | 0.86% | 0.90% | 0.95% | Q2 2013 | Q3 2013 | 2 |
| VIXY | PROSHARES TR II | 2 | 2 | 0.56% | 0.88% | 1.20% | Q2 2021 | Q3 2021 | 2 |
| VVUS | VIVUS INC | 2 | 2 | 0.46% | 0.84% | 1.22% | Q2 2013 | Q3 2013 | 2 |
| SNSS | SUNESIS PHARMACEUTICAL... | 2 | 2 | 0.58% | 0.81% | 1.04% | Q3 2016 | Q4 2016 | 2 |
| BAX | BAXTER INTL INC | 2 | 2 | 0.48% | 0.75% | 1.02% | Q4 2013 | Q1 2014 | 2 |
| SGNT | SAGENT PHARMACEUTICALS... | 2 | 2 | 0.63% | 0.63% | 0.64% | Q1 2016 | Q2 2016 | 2 |
| ARLZ | ARALEZ PHARMACEUTICALS... | 2 | 2 | 0.30% | 0.61% | 0.91% | Q1 2016 | Q2 2016 | 2 |
| CEMP | CEMPRA INC | 2 | 2 | 0.45% | 0.49% | 0.53% | Q2 2014 | Q3 2014 | 2 |
| SCMP | SUCAMPO PHARMACEUTICAL... | 2 | 2 | 0.32% | 0.44% | 0.56% | Q2 2014 | Q3 2014 | 2 |
| GLMD | GALMED PHARMACEUTICALS... | 2 | 2 | 0.38% | 0.39% | 0.41% | Q1 2014 | Q2 2014 | 2 |
| ALIM | ALIMERA SCIENCES INC | 2 | 2 | 0.27% | 0.39% | 0.51% | Q4 2014 | Q1 2015 | 2 |
| FOMX | FOAMIX PHARMACEUTICALS... | 2 | 2 | 0.28% | 0.38% | 0.49% | Q3 2019 | Q4 2019 | 2 |
| ANAC | ANACOR PHARMACEUTICALS... | 2 | 2 | 0.15% | 0.25% | 0.35% | Q2 2013 | Q3 2013 | 2 |
| ZIOP | ZIOPHARM ONCOLOGY INC | 2 | 2 | 0.15% | 0.25% | 0.34% | Q2 2013 | Q3 2013 | 2 |
| TYME | TYME TECHNOLOGIES INC | 2 | 2 | 0.22% | 0.22% | 0.23% | Q2 2019 | Q3 2019 | 2 |
| APRI | APRICUS BIOSCIENCES INC | 2 | 2 | 0.16% | 0.19% | 0.21% | Q3 2015 | Q4 2015 | 2 |
| ALBANY MOLECULAR RESH INC | 1 | 1 | 7.91% | 7.91% | 7.91% | Q3 2016 | Q3 2016 | 1 | |
| CRY | CRYOLIFE INC | 1 | 1 | 7.17% | 7.17% | 7.17% | Q2 2017 | Q2 2017 | 1 |
| ABBV | ABBVIE INC | 1 | 1 | 6.82% | 6.82% | 6.82% | Q2 2019 | Q2 2019 | 1 |
| JNJ | JOHNSON & JOHNSON | 1 | 1 | 6.53% | 6.53% | 6.53% | Q2 2019 | Q2 2019 | 1 |
| ALKS | ALKERMES PLC | 1 | 1 | 6.09% | 6.09% | 6.09% | Q3 2021 | Q3 2021 | 1 |
| B108PS | ACTAVIS PLC | 1 | 1 | 5.82% | 5.82% | 5.82% | Q3 2014 | Q3 2014 | 1 |
| LH | LABORATORY CORP AMER H... | 1 | 1 | 5.32% | 5.32% | 5.32% | Q1 2020 | Q1 2020 | 1 |
| SPXL | DIREXION SHS ETF TR | 1 | 1 | 5.26% | 5.26% | 5.26% | Q1 2020 | Q1 2020 | 1 |
| WCG | WELLCARE HEALTH PLANS INC | 1 | 1 | 5.19% | 5.19% | 5.19% | Q1 2014 | Q1 2014 | 1 |
| CVS | CVS HEALTH CORP | 1 | 1 | 5.11% | 5.11% | 5.11% | Q2 2019 | Q2 2019 | 1 |
| DEPO | DEPOMED INC | 1 | 1 | 4.87% | 4.87% | 4.87% | Q3 2017 | Q3 2017 | 1 |
| BAX | BAXTER INTL INC | 1 | 1 | 4.81% | 4.81% | 4.81% | Q1 2014 | Q1 2014 | 1 |
| ALXN | ALEXION PHARMACEUTICAL... | 1 | 1 | 4.53% | 4.53% | 4.53% | Q1 2020 | Q1 2020 | 1 |
| PFE | PFIZER INC | 1 | 1 | 4.25% | 4.25% | 4.25% | Q3 2021 | Q3 2021 | 1 |
| AMGN | AMGEN INC | 1 | 1 | 3.92% | 3.92% | 3.92% | Q4 2016 | Q4 2016 | 1 |
| MDXG | MIMEDX GROUP INC | 1 | 1 | 3.12% | 3.12% | 3.12% | Q2 2021 | Q2 2021 | 1 |
| EGRX | EAGLE PHARMACEUTICALS INC | 1 | 1 | 2.98% | 2.98% | 2.98% | Q1 2016 | Q1 2016 | 1 |
| AUPH | AURINIA PHARMACEUTICAL... | 1 | 1 | 2.89% | 2.89% | 2.89% | Q1 2021 | Q1 2021 | 1 |
| MYL | MYLAN N V | 1 | 1 | 2.87% | 2.87% | 2.87% | Q3 2015 | Q3 2015 | 1 |
| ARAY | ACCURAY INC | 1 | 1 | 2.82% | 2.82% | 2.82% | Q2 2013 | Q2 2013 | 1 |
| BMY | BRISTOL MYERS SQUIBB CO | 1 | 1 | 2.47% | 2.47% | 2.47% | Q3 2014 | Q3 2014 | 1 |
| UVXY | PROSHARES TR II | 1 | 1 | 2.42% | 2.42% | 2.42% | Q3 2021 | Q3 2021 | 1 |
| BIS | PROSHARES TR | 1 | 1 | 2.39% | 2.39% | 2.39% | Q2 2014 | Q2 2014 | 1 |
| GIVN | GIVEN IMAGING | 1 | 1 | 2.21% | 2.21% | 2.21% | Q4 2013 | Q4 2013 | 1 |
| LLY | LILLY ELI & CO | 1 | 1 | 2.20% | 2.20% | 2.20% | Q3 2013 | Q3 2013 | 1 |
| LLY | LILLY ELI & CO | 1 | 1 | 2.20% | 2.20% | 2.20% | Q3 2013 | Q3 2013 | 1 |
| TECH | TECHNE CORP | 1 | 1 | 2.00% | 2.00% | 2.00% | Q2 2013 | Q2 2013 | 1 |
| GWPH | GW PHARMACEUTICALS PLC | 1 | 1 | 1.94% | 1.94% | 1.94% | Q2 2019 | Q2 2019 | 1 |
| BPAX | BIOSANTE PHARMACEUTICA... | 1 | 1 | 1.84% | 1.84% | 1.84% | Q2 2013 | Q2 2013 | 1 |
| VRTX | VERTEX PHARMACEUTICALS... | 1 | 1 | 1.79% | 1.79% | 1.79% | Q3 2021 | Q3 2021 | 1 |
| CEMP | CEMPRA INC | 1 | 1 | 1.72% | 1.72% | 1.72% | Q4 2014 | Q4 2014 | 1 |
| VPHM | VIROPHARMA INC | 1 | 1 | 1.72% | 1.72% | 1.72% | Q3 2013 | Q3 2013 | 1 |
| ALXN | ALEXION PHARMACEUTICAL... | 1 | 1 | 1.67% | 1.67% | 1.67% | Q2 2013 | Q2 2013 | 1 |
| SLTM | SOLTA MED INC | 1 | 1 | 1.62% | 1.62% | 1.62% | Q3 2013 | Q3 2013 | 1 |
| AUXL | AUXILIUM PHARMACEUTICA... | 1 | 1 | 1.59% | 1.59% | 1.59% | Q3 2013 | Q3 2013 | 1 |
| CRON | CRONOS GROUP INC | 1 | 1 | 1.50% | 1.50% | 1.50% | Q2 2019 | Q2 2019 | 1 |
| FRX | FOREST LABS INC | 1 | 1 | 1.49% | 1.49% | 1.49% | Q2 2013 | Q2 2013 | 1 |
| OFIX | ORTHOFIX INTL N V | 1 | 1 | 1.39% | 1.39% | 1.39% | Q2 2013 | Q2 2013 | 1 |
| IPXL | IMPAX LABORATORIES INC | 1 | 1 | 1.26% | 1.26% | 1.26% | Q2 2014 | Q2 2014 | 1 |
| WCG | WELLCARE HEALTH PLANS INC | 1 | 1 | 1.21% | 1.21% | 1.21% | Q2 2013 | Q2 2013 | 1 |
| NUVA | NUVASIVE INC | 1 | 1 | 1.18% | 1.18% | 1.18% | Q2 2013 | Q2 2013 | 1 |
| HMA | HEALTH MGMT ASSOC INC NEW | 1 | 1 | 1.14% | 1.14% | 1.14% | Q2 2013 | Q2 2013 | 1 |
| MDCO | MEDICINES CO | 1 | 1 | 1.12% | 1.12% | 1.12% | Q2 2013 | Q2 2013 | 1 |
| ITMN | INTERMUNE INC | 1 | 1 | 1.10% | 1.10% | 1.10% | Q1 2014 | Q1 2014 | 1 |
| STJ | ST JUDE MED INC | 1 | 1 | 1.04% | 1.04% | 1.04% | Q2 2013 | Q2 2013 | 1 |
| TRGT | TARGACEPT INC | 1 | 1 | 0.94% | 0.94% | 0.94% | Q3 2013 | Q3 2013 | 1 |
| TWM | PROSHARES TR | 1 | 1 | 0.88% | 0.88% | 0.88% | Q4 2013 | Q4 2013 | 1 |
| ACAD | ACADIA PHARMACEUTICALS... | 1 | 1 | 0.82% | 0.82% | 0.82% | Q1 2016 | Q1 2016 | 1 |
| KITE | KITE PHARMA INC | 1 | 1 | 0.76% | 0.76% | 0.76% | Q3 2016 | Q3 2016 | 1 |
| MDCO | MEDICINES CO | 1 | 1 | 0.73% | 0.73% | 0.73% | Q3 2013 | Q3 2013 | 1 |
| PTX | PERNIX THERAPEUTICS HL... | 1 | 1 | 0.73% | 0.73% | 0.73% | Q4 2015 | Q4 2015 | 1 |
| POZN | POZEN INC | 1 | 1 | 0.73% | 0.73% | 0.73% | Q4 2014 | Q4 2014 | 1 |
| BSX | BOSTON SCIENTIFIC CORP | 1 | 1 | 0.67% | 0.67% | 0.67% | Q2 2013 | Q2 2013 | 1 |
| PCYC | PHARMACYCLICS INC | 1 | 1 | 0.66% | 0.66% | 0.66% | Q1 2014 | Q1 2014 | 1 |
| DRRX | DURECT CORP | 1 | 1 | 0.63% | 0.63% | 0.63% | Q3 2021 | Q3 2021 | 1 |
| CRTX | CORNERSTONE THERAPEUTI... | 1 | 1 | 0.63% | 0.63% | 0.63% | Q2 2013 | Q2 2013 | 1 |
| SPPI | SPECTRUM PHARMACEUTICA... | 1 | 1 | 0.54% | 0.54% | 0.54% | Q2 2013 | Q2 2013 | 1 |
| NBIX | NEUROCRINE BIOSCIENCES... | 1 | 1 | 0.50% | 0.50% | 0.50% | Q3 2013 | Q3 2013 | 1 |
| ESRX | EXPRESS SCRIPTS HLDG CO | 1 | 1 | 0.45% | 0.45% | 0.45% | Q2 2013 | Q2 2013 | 1 |
| VNDA | VANDA PHARMACEUTICALS INC | 1 | 1 | 0.44% | 0.44% | 0.44% | Q2 2013 | Q2 2013 | 1 |
| SPPI | SPECTRUM PHARMACEUTICA... | 1 | 1 | 0.43% | 0.43% | 0.43% | Q2 2013 | Q2 2013 | 1 |
| ACHI | ACCRETIVE HEALTH INC | 1 | 1 | 0.38% | 0.38% | 0.38% | Q2 2013 | Q2 2013 | 1 |
| ZGNX | ZOGENIX INC | 1 | 1 | 0.37% | 0.37% | 0.37% | Q1 2014 | Q1 2014 | 1 |
| MNKD | MANNKIND CORP | 1 | 1 | 0.35% | 0.35% | 0.35% | Q4 2017 | Q4 2017 | 1 |
| XNPT | XENOPORT INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q4 2013 | Q4 2013 | 1 |
| XOMA | XOMA CORP DEL | 1 | 1 | 0.29% | 0.29% | 0.29% | Q2 2015 | Q2 2015 | 1 |
| FURX | FURIEX PHARMACEUTICALS... | 1 | 1 | 0.28% | 0.28% | 0.28% | Q1 2014 | Q1 2014 | 1 |
| ARNA | ARENA PHARMACEUTICALS INC | 1 | 1 | 0.28% | 0.28% | 0.28% | Q2 2013 | Q2 2013 | 1 |
| CPRX | CATALYST PHARM PARTNER... | 1 | 1 | 0.27% | 0.27% | 0.27% | Q4 2014 | Q4 2014 | 1 |
| ACHN | ACHILLION PHARMACEUTIC... | 1 | 1 | 0.26% | 0.26% | 0.26% | Q3 2013 | Q3 2013 | 1 |
| AMAG | AMAG PHARMACEUTICALS INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q1 2014 | Q1 2014 | 1 |
| XNPT | XENOPORT INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q3 2013 | Q3 2013 | 1 |
| FCSC | FIBROCELL SCIENCE INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2017 | Q1 2017 | 1 |
Download | |||||||||
The securities at the top of the list , including GILEAD SCIENCES INC, GLAXOSMITHKLINE PLC, and PFIZER INC, are the highest-conviction holdings of Healthcare Value Capital, LLC.
The conviction is calculated by counting the number of quarters a security has been reported by Healthcare Value Capital, LLC. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Healthcare Value Capital, LLC owns currently or has owned in the past.